A Randomized Phase II study of Z-endoxifen and Tamoxifen in Metastatic Endocrine Refractory, Estrogen Receptor Positive, HER2 negative Metastatic Breast cancer (Alliance)
- Citation:
- Meeting Instance:
- SABCS 2025
- Year:
- 2025
- Type:
- Abstract
- Sub type:
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Parents:
- None
- Children:
- 4781
